MX2023000947A - Peptidos grapados y metodos para su obtencion. - Google Patents

Peptidos grapados y metodos para su obtencion.

Info

Publication number
MX2023000947A
MX2023000947A MX2023000947A MX2023000947A MX2023000947A MX 2023000947 A MX2023000947 A MX 2023000947A MX 2023000947 A MX2023000947 A MX 2023000947A MX 2023000947 A MX2023000947 A MX 2023000947A MX 2023000947 A MX2023000947 A MX 2023000947A
Authority
MX
Mexico
Prior art keywords
present disclosure
disclosure provides
catenin
beta
agents
Prior art date
Application number
MX2023000947A
Other languages
English (en)
Spanish (es)
Inventor
Yue - Mei Zhang
John Hanney Mcgee
Brian Halbert White
Yaguang Si
Martin Robert Tremblay
Deborah Gail Conrady
Ivan Tucker Jewett
Lorenzo Josue Alfaro-Lopez
Sarah Isabelle Cappucci
Zhi Li
Original Assignee
Fog Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fog Pharmaceuticals Inc filed Critical Fog Pharmaceuticals Inc
Publication of MX2023000947A publication Critical patent/MX2023000947A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2023000947A 2020-07-22 2021-07-22 Peptidos grapados y metodos para su obtencion. MX2023000947A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063055308P 2020-07-22 2020-07-22
US202163208494P 2021-06-08 2021-06-08
PCT/US2021/042856 WO2022020652A2 (en) 2020-07-22 2021-07-22 Stapled peptides and methods thereof

Publications (1)

Publication Number Publication Date
MX2023000947A true MX2023000947A (es) 2023-02-22

Family

ID=79728982

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023000947A MX2023000947A (es) 2020-07-22 2021-07-22 Peptidos grapados y metodos para su obtencion.

Country Status (10)

Country Link
US (1) US20240116985A1 (cg-RX-API-DMAC10.html)
EP (1) EP4185599A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023535026A (cg-RX-API-DMAC10.html)
KR (1) KR20230057350A (cg-RX-API-DMAC10.html)
CN (1) CN116323638A (cg-RX-API-DMAC10.html)
AU (1) AU2021314310A1 (cg-RX-API-DMAC10.html)
CA (1) CA3186681A1 (cg-RX-API-DMAC10.html)
IL (1) IL299907A (cg-RX-API-DMAC10.html)
MX (1) MX2023000947A (cg-RX-API-DMAC10.html)
WO (1) WO2022020652A2 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020004555A2 (pt) 2017-09-07 2020-09-24 Fog Pharmaceuticals, Inc. agentes que modulam funções de beta-catenina e métodos dos mesmos
AU2019326423A1 (en) 2018-08-20 2021-04-08 Fog Pharmaceuticals, Inc. Collections of peptides, peptide agents, and methods of use thereof
BR112023025528A2 (pt) * 2021-06-08 2024-02-27 Fog Pharmaceuticals Inc Peptídeos grampeados e métodos destes
CN115260060A (zh) * 2022-09-07 2022-11-01 康化(上海)新药研发有限公司 (2s)-2-n-芴甲氧羰基氨基-5,5-二甲基正亮氨酸的合成方法
WO2024054892A1 (en) * 2022-09-09 2024-03-14 Shape Therapeutics Inc. Therapeutic peptides
US20260207704A1 (en) * 2022-12-15 2026-07-23 Parabilis Medicines, Inc. Stapled peptides and methods thereof
WO2024130217A1 (en) * 2022-12-15 2024-06-20 Fog Pharmaceuticals, Inc. Stapled peptides and methods thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5671196A (en) * 1996-03-28 1997-10-17 Immulogic Pharmaceutical Corporation Myelin oligodendrocyte glycoprotein peptides and uses thereof
US20040181830A1 (en) * 2001-05-07 2004-09-16 Kovalic David K. Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
US20050187147A1 (en) * 2003-09-22 2005-08-25 Newman Michael J. Compositions and methods for increasing drug efficiency
WO2009106073A2 (en) * 2008-02-28 2009-09-03 Dako Denmark A/S Mhc multimers in borrelia diagnostics and disease
KR101706789B1 (ko) * 2008-07-21 2017-02-14 프로비오드룩 아게 진단용 항체 검사법
WO2010037395A2 (en) * 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
WO2012040459A2 (en) * 2010-09-22 2012-03-29 President And Fellows Of Harvard College Beta-catenin targeting peptides and uses thereof
WO2014026033A1 (en) * 2012-08-08 2014-02-13 University Of Florida Research Foundation, Inc. Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats
GB2563875B (en) * 2017-06-28 2020-08-19 Sutura Therapeutics Ltd Improvements in drug delivery
BR112020004555A2 (pt) * 2017-09-07 2020-09-24 Fog Pharmaceuticals, Inc. agentes que modulam funções de beta-catenina e métodos dos mesmos
EP3765852A1 (en) * 2018-03-14 2021-01-20 Dana Farber Cancer Institute, Inc. Stabilized peptides for biomarker detection

Also Published As

Publication number Publication date
WO2022020652A2 (en) 2022-01-27
WO2022020652A3 (en) 2022-03-03
KR20230057350A (ko) 2023-04-28
CA3186681A1 (en) 2022-01-27
JP2023535026A (ja) 2023-08-15
AU2021314310A1 (en) 2023-03-16
US20240116985A1 (en) 2024-04-11
EP4185599A4 (en) 2024-08-28
EP4185599A2 (en) 2023-05-31
CN116323638A (zh) 2023-06-23
IL299907A (en) 2023-03-01

Similar Documents

Publication Publication Date Title
WO2022020652A3 (en) Stapled peptides and methods thereof
BR112023025528A2 (pt) Peptídeos grampeados e métodos destes
MX2020002435A (es) Agentes que modulan las funciones de beta-catenina y sus métodos.
PH12022550932A1 (en) Glp-1r modulating compounds
CR20220396A (es) Anticuerpos y proteínas de fusión que se unen a ccr8 y usos de estos
PH12023552860A1 (en) Carboxy-benzimidazole glp-1r modulating compounds
PH12023552861A1 (en) Carboxy-benzimidazole glp-1r modulating compounds
WO2019178269A3 (en) Antibodies that bind cd39 and uses thereof
WO2021178749A3 (en) Anti-ccr8 agents
MX2018009498A (es) Anticuerpos anti-tnf, composiciones, métodos y uso para el tratamiento o la prevención de la diabetes tipo 1.
ZA201801083B (en) Single domain antibody for programmed death-ligand (pd-l1) and derived protein thereof
PH12016500081A1 (en) Immunoglobulin variants and uses thereof
EP3939994A3 (en) Compositions and methods for cd20 immunotherapy
MX2022008659A (es) Moléculas de anticuerpos específicos contra c5ar1 y usos de estas.
EA202190708A1 (ru) Модуляторы экспрессии pnpla3
SG170793A1 (en) Anti-mn antibodies and methods of using same
MY205398A (en) Variants of cd38 antibody and uses thereof
NZ755083A (en) Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis
ES2675375T3 (es) Anticuerpos monoclonales contra claudina 18 para el tratamiento del cáncer
PE20140673A1 (es) Nuevos moduladores y metodos para su uso
EA200901067A1 (ru) Использование семафорина 6а в качестве промотора миелинизации и дифференцировки олигодендроцитов
EA201890320A1 (ru) Молекулы антител, которые связывают cd79
WO2017040380A3 (en) Engineered antibody fc variants
AU2019321490A8 (en) Ox40-binding polypeptides and uses thereof
CN116669770A8 (zh) 甲基丙烯酰胺蛋白质结合剂及其用途